Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer

Radiology

Volumn 235, Issue 1, 2005, Pages 208-215

  Tae, Hyun Kim ^a   Kwan, Ho Cho ^a   Hong, Ryull Pyo ^a   Jin, Soo Lee ^a   Jae, Iii Zo ^a   Dae, Ho Lee ^a   Jong, Mog Lee ^a   Hyae, Young Kim ^a   Hwangbo, Bin ^a   Sung, Yong Park ^a   Joo, Young Kim ^a   Kyung, Hwan Shin ^a   Dae, Yong Kim ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER THERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONFORMATION; CORRELATION ANALYSIS; DISEASE COURSE; DOSIMETRY; FEMALE; FISHER EXACT TEST; FORCED EXPIRATORY VOLUME; GENDER; HUMAN; LUNG CANCER; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONSET AGE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION PNEUMONIA; THREE DIMENSIONAL IMAGING; WEIGHT REDUCTION;

ADULT; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIATION PNEUMONITIS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 20144388394     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2351040248     Document Type: Article

References (41)

1. Seppenwoolde Y, Lebesque JV. Partial irradiation of the lung. Semin Radiat Oncol 2001; 11:247-258.
2. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21:109-122.
3. Robertson JM, Ten Haken RK, Hazuka MB, et al. Dose escalation for non-small-cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37:1079-1085.
4. Martel MK, Ten Haken RK, Hazuka MB, Turrisi AT, Fraass BA, Lichter AS. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 1994; 28:575-581.
5. Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998; 42:1-9.
6. Oetzel D, Schraube P, Hensley F, Sroka-Perez G, Menke M, Flentje M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995; 33:455-460.
7. Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001; 51:650-659.
8. Allen AM, Henning GT, Ten Haken RK, Hayman JA, Martel MK. Do dose-volume metrics predict pulmonary function changes in lung irradiation? Int J Radiat Oncol Biol Phys 2003; 55:921-929.
9. Marks LB, Munley MT, Bentel GC, et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 1997; 39:563-570.
10. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45:323-329.
11. American Joint Committee on Cancer. AJCC cancer staging manual. 5th ed. Philadelphia, Pa: Lippincott-Raven, 1997; 127-137.
12. Bentel G. Positioning and immobilization of patients undergoing radiation therapy for Hodgkin's disease. Med Dosim 1991; 16:111-117.
13. Lagerwaard FJ, Van Sornsen de Koste JR, Nijssen-Visser MR, et al. Multiple "slow" CT scans for incorporating lung tumor mobility in radiotherapy planning. Int J Radiat Oncol Biol Phys 2001; 51:932-937.
14. Kutcher GJ, Burman C. Calculation of complication probability for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989; 16:1623-1630.
15. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21:123-135.
16. Wang JY, Chen KY, Wang JT, et al. Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis. Int J Radiat Oncol Biol Phys 2002; 54:735-741.
17. Mehta CR. The exact analysis of contingency tables in medical research. Stat Methods Med Res 1994; 3:135-156.
18. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Belmont, Calif: Duxbury, 1988; 512-516.
19. Casella G, Berger RL. Statistical inference. Belmont, Calif: Duxbury, 1990; 160-168.
20. Marks LB. The pulmonary effects of thoracic irradiation. Oncology (Huntingt) 1994; 8:89-106.
21. Byhardt RW, Martin L, Pajak TF, Shin KH, Emami B, Cox JD. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC): analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int J Radiat Oncol Biol Phys 1993; 27:537-544.
22. Komaki R, Cox JD. The lung and thymus. In: Cox JD, ed. Moss' radiation oncology: rationale, technique, results. 7th ed. St Louis, Mo: Mosby-Year Book, 1994; 320-325.
23. Robnett TJ, Machtay M, Vines EF, McKenna MG, Algazy KM, McKenna WG. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000; 48:89-94.
24. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003; 67:275-283.
25. Johansson S, Bjermer L, Franzen L, Henriksson R. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 1998; 49:41-47.
26. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/ etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 1996; 14:1065-1070.
27. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992; 326:524-530.
28. Inoue A, Kunitoh H, Sekine I, Sumi M, Tokuuye K, Saijo N. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 2001; 49:649-655.
29. Yamada M, Kudoh S, Hirata K, Nakajima T, Yoshikawa J. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 1998; 34:71-75.
30. Quon H, Shepherd FA, Payne DG, et al. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 1999; 43:39-45.
31. Byhardt RW, Scott C, Sause WT, et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1998; 42:469-478.
32. Roach M 3rd, Gandara DR, Yuo HS, et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 1995; 13:2606-2612.
33. Robert F, Childs HA, Spencer SA, Redden DT, Hawkins MM. Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity. Semin Radiat Oncol 1999; 9(suppl 1):136-147.
34. Brooks BJ Jr, Seifter EJ, Walsh TE, et al. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. J Clin Oncol 1986; 4:200-209.
35. Armstrong JG, Zelefsky MJ, Leibel SA, et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol 1995; 6:693-697.
36. Tsujino K, Hirota S, Endo M, et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003; 55:110-115.
37. Marks LB. Dosimetric predictors of radiation-induced lung injury. Int J Radiat Oncol Biol Phys 2002; 54:313-316.
38. Klein EE, Morrison A, Purdy JA, Graham MV, Matthews J. A volumetric study of measurements and calculations of lung density corrections for 6 and 18 MV photons. Int J Radiat Oncol Biol Phys 1997; 37:1163-1170.
39. Orton CG, Chungbin S, Klein EE, Gillin MT, Schultheiss TE, Sause WT. Study of lung density corrections in a clinical trial (RTOG 88-08). Int J Radiat Oncol Biol Phys 1998; 41:787-794.
40. Papanikolaou N, Klein EE. Heterogeneity corrections should be used in treatment planning for lung cancer. Med Phys 2000; 27:1702-1704.
41. Frank SJ, Forster KM, Stevens CW, et al. Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. Int J Radiat Oncol Biol Phys 2003; 56:1308-1318.